(Q33421189)

26 July 2017

title

Lysophosphatidylcholine--biomarker of Metformin action: studied using UPLC/MS/MS. (English)

1 reference

26 July 2017

0 references

1 reference

Shuang Cai

1

1 reference

26 July 2017

Taoguang Huo

2

1 reference

26 July 2017

Ning Li

3

1 reference

26 July 2017

Zhili Xiong

4

1 reference

26 July 2017

Famei Li

5

1 reference

26 July 2017

publication date

1 July 2009

1 reference

Biomedical Chromatography

26 July 2017

published in

1 reference

26 July 2017

volume

23

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

782-786

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1185

26 July 2017

1 reference

Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1185

Crossref

reference URL

Metformin monotherapy for type 2 diabetes mellitus

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002966.PUB3

The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements

1 reference

5 May 2024

https://opencitations.net/index/api/v1/citations/10.2217/14622416.6.7.691

Identifiers

DOI

10.1002/BMC.1185

1 reference

26 July 2017

1 reference